Education
About Us
Working with TipRanks
Follow Us
Oncology Institute, Inc. (TOI)
NASDAQ:TOI
TOI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.13 - $4.50
Previous CloseN/A
Volume198.36K
Average Volume (3M)2.01M
Market Cap
$326.33M
Enterprise Value$263.93M
Total Cash (Recent Filing)$30.29M
Total Debt (Recent Filing)$103.16M
Price to Earnings (P/E)―
Beta1.36
Next Earnings
Nov 05, 2025EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.15
Shares Outstanding93,504,770
10 Day Avg. Volume1,926,887
30 Day Avg. Volume2,010,124
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.81
Enterprise Value/Revenue0.62
Enterprise Value/Gross Profit4.26
Enterprise Value/Ebitda-5.46
Forecast
1Y Price Target
$7.00Price Target Upside102.31% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Bulls Say, Bears Say
Bulls Say
EarningsTOI offers an attractive risk/reward profile given the operating margin improvement trajectory and path to cash flow positivity.
ExpansionTOI continues to expand into new markets and increase the number of patients served, driven by macro trends and a differentiated business model.
Financial PerformanceThe recent debt facility amendment has eliminated a key financial overhang, and management is guiding toward cash flow and adjusted EBITDA breakeven.
Bears Say
Business Model TransitionTOI is working to transition some patients from a fee-for-service model to value-based-care, with ~46% of revenue in 2024 coming from VBC contracts.
Cost ManagementMargins are expected to improve as TOI signed an improved contract, reduced SG&A costs, and is focusing on driving earnings, aiming for positive EBITDA and FCF.
Oncology Institute News
TOI FAQ
What was Oncology Institute, Inc.’s price range in the past 12 months?
Oncology Institute, Inc. lowest stock price was $0.13 and its highest was $4.50 in the past 12 months.
What is Oncology Institute, Inc.’s market cap?
Oncology Institute, Inc.’s market cap is $326.33M.
When is Oncology Institute, Inc.’s upcoming earnings report date?
Oncology Institute, Inc.’s upcoming earnings report date is Nov 05, 2025 which is in 68 days.
How were Oncology Institute, Inc.’s earnings last quarter?
Oncology Institute, Inc. released its earnings results on Aug 13, 2025. The company reported -$0.15 earnings per share for the quarter, missing the consensus estimate of -$0.12 by -$0.03.
Is Oncology Institute, Inc. overvalued?
According to Wall Street analysts Oncology Institute, Inc.’s price is currently Undervalued.
Does Oncology Institute, Inc. pay dividends?
Oncology Institute, Inc. does not currently pay dividends.
What is Oncology Institute, Inc.’s EPS estimate?
Oncology Institute, Inc.’s EPS estimate is -0.12.
How many shares outstanding does Oncology Institute, Inc. have?
Oncology Institute, Inc. has 93,504,770 shares outstanding.
What happened to Oncology Institute, Inc.’s price movement after its last earnings report?
Oncology Institute, Inc. reported an EPS of -$0.15 in its last earnings report, missing expectations of -$0.12. Following the earnings report the stock price went down -10.488%.
Which hedge fund is a major shareholder of Oncology Institute, Inc.?
Currently, no hedge funds are holding shares in TOI
Oncology Institute Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$7.00 (102.31% Upside)
$7.00 (102.31% Upside)
Blogger Sentiment
Bullish
TOI Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 1.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $8.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 7.1%
Last 30 Days ▲ 13.1%
Last 30 Days ▲ 13.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
880.16%
12-Months-Change
Fundamentals
Return on Equity
-535.24%
Trailing 12-Months
Asset Growth
-11.03%
Trailing 12-Months
Company Description
Oncology Institute, Inc.
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
TOI Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presents a predominantly positive outlook for the Oncology Institute with strong revenue growth, significant expansion in capitated contracts, and a positive forecast for adjusted EBITDA by year-end. Despite some challenges such as adjusted EBITDA loss and a sequential gross margin decline, the strategic focus on leadership, technology, and pharmacy business growth positions the company favorably.View all TOI earnings summariesTOI Stock 12 Month Forecast
Average Price Target
$7.00
▲(102.31% Upside)
Technical Analysis
Acadia Healthcare
―
Community Health
―
Encompass Health
―
National Healthcare
―
Select Medical
―
Ownership Overview
23.82% Insiders
2.22% Mutual Funds
12.64% Other Institutional Investors
54.41% Public Companies and
Individual Investors